2 Important CMS Updates for GI Practices: Biosimilar Changes and Medicare Appeals Guidance

Medicare Part B Biosimilar Payment and Required New Codes: Dates of Service on or after April 1, 2018 Pursuant to a recent CMS update, the “Quarterly Healthcare Common Procedure Coding System (HCPCS) Drug/Biological Code Changes – April ...

Case Series Raises Awareness of Infliximab Associated Psoriasiform Alopecia

  Zenas Yiu, MBChB, MRCP Poster 1798 Infliximab Associated Psoriasiform Alopecia Author Insight from Zenas Yiu, MBChB, MRCP, University of Manchester What’s new here and important for clinicians? This case series raises awareness of the phenomenon ...

Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids: A Systematic Review and Meta-Analysis

Plenary Session 2: IBD Monday, October 20 2:15 pm – 3:00 pm MODERATORS:     Uma Mahadevan, MD, FACG Sunanda V. Kane, MD, MSPH, FACG Oral 15: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory ...